Professional Documents
Culture Documents
Infection represents a significant cause of neonatal mortality in low resource settings Exposure to pathogens is high at birth and immediate postpartum Umbilical cord vessels are open for 2448 hours after birth Stump is rapidly colonized
~50 years ago: nearly universal use of topical antiseptics in facilities of high income countries ~25-40 years ago: MANY studies on topical antiseptics to examine:
Topical antiseptics reduce exposure to pathogens Less direct evidence for reduction in infection / death
By late 1990s, large literature, but almost NONE from places with high infection risk
WHO Guidelines
Recognizing a lack of clear evidence, WHO provided 3 key recommendations: 1. Promote keeping the cord clean / dry 2. Topical antiseptic could be used where infection/exposure risk is high 3. Research needed for optimal guidelines for high risk settings
*WHO. Care of the umbilical cord. WHO. Geneva, 1998. WHO/RHT/MSM 98.4
Why Chlorhexidine?
Broad spectrum antiseptic solution Readily available, worldwide Excellent safety record Superior to many other choices for reducing cord pathogens WHO Model List of Essential Medicines for cord cleansing Evidence for reduction of mortality
Nepal 32 / 1000 92% 413 (700) All live births in study area 133 (4000) All live births in study area 88% 36 / 1000
Bangladesh
Pakistan 30 / 1000 80% 187 (1000) All live births in study area
Overall NMR
% Home Births
Eligibility
Exclusion
Intervention Provided
Nepal Dry Cord Care Dry Cord Care Bangladesh Pakistan Dry Cord Care
Comparison Group
Intervention Groups
CHX Concentration
1,2,3,4,5,6,7
Intervention Provider
TBA to caretaker
CDK, Fe/FA, TT, promotion of ANC/ENC Mortality Omphalitis 15,123 ~5050 1,2,3,4,6,8,10,12, 14,21,28 Mortality Omphalitis 29,760 ~9,900 1,3,6,9,15,28
Basic comp of ENC as promoted by MoH Mortality Omphalitis 9,741 ~4,850 1,3,5,7,14,28
Primary Outcomes
Follow Up Days
Nepal 24% lower mortality at 28 days (multiple CHX) 34% lower mortality if initiated within 24 hours No impact of Soap/H2O cleansing
Bangladesh 20% lower mortality at 28 days (single CHX) 6% lower mortality at 28 days (multiple CHX, NS) Strong evidence of impact among preterm babies
Study
Nepal reduction in mortality 0.76 (0.58, 1.00) 23% among Bangladesh 0.88 (0.74, 1.04) those receiving intervention Pakistan 0.62 (0.45, 0.85) 0.77 (0.63, 0.94)
Overall
.5
.75
1.2
In all studies Multiple CHX reduced cord infection Nepal: 33% 75% reduction Bangladesh: 15% 45% reduction Pakistan: 40% 50% reduction
Severe Infection: Any Any CHX CHX vs. vs. No No CHX CHX Cord Infection:
RR (95% CI)
Study
0.25 (0.13, 0.51) 59% reduction in serious cord Bangladesh 0.55 (0.30, 1.01) infection among those 0.51 receiving Pakistan (0.18, 1.45) Overall chlorhexidine0.41 (0.24, 0.69)
Nepal
.1
.25
.5
1.5
Bloodstream infection
No bloodstream infection
Survival
Death
Survival
Day
HIGH MEDIUM LOWER
14
Mortality Risk
Visible infection
Sepsis
Death
Is chlorhexidine safe?
Yes, chx has been in common use for 60 years, and has excellent safety record. No reported adverse events when used on umbilical cord
Yes, one of the most commonly used topical antiseptics in the world
TRUE any action that keeps the cord cleaner, will delay cord separation time This is important from a programmatic experience and for shaping acceptance What is more important?
saving lives and reducing infection OR Have cord fall off on day 5 instead of day 6?
All three of the big trials tell us the opposite There are no community-based randomized trials of promotion of dry and clean cord practices showing impact on mortality Why not? Because keeping cord clean and avoiding pathogens is very difficult (~80%90% of cords colonized immediately)
We wont benefit from chlorhexidine because harmful practices are no longer common
Not necessarily true. The cord stump is still exposed to pathogens through routine home and facility practices Among babies where caretakers followed suggested cleaned cord practices, chlorhexidine still reduced infection and mortality
Not true. Facility born babies in the Bangladesh and Nepal trials had:
Lower mortality if they got chlorhexidine Lower risk of cord infection Reduced colonization of the cord and same relationship between cord separation time and cord care, as seen in home births
facilities also struggle to achieve hygienic practices babies are discharged into same environment as home-born babies
Common Questions/Points
Alcohol not good for preterm skin Gentian violet not sufficiently bacteriocidal Iodine too easily absorbed through skin All high quality evidence from communitysettings is based on chlorhexidine
Evidence from higher-risk populations was not available More research was needed to define optimal cord care Topical antiseptic such as chlorhexidine could be used if exposure to the cord was likely
As public health professionals we are obligated to update recommendations and policies if evidence emerges that warrants change
Messages can be shaped to fit consistently with promotion of clean cord care Topical chlorhexidine can be promoted as a tool to help caretakers achieve a clean cord
Even if conflict, this is NOT a valid reason for INACTION, if the evidence exists.
Final Thoughts
CHX is safe, acceptable CHX can have various formulations, packaging, distribution models Cleansing should begin as early as possible after birth CHX cord cleansing can save hundreds of thousands of lives, at very low cost
Nepal: NNIPS, JHU, IOM-Tribhuvan University, NICHD, Bill & Melinda Gates Foundation, USAID, Proctor and Gamble, MoHP, Nepal Family Health Project
Bangladesh: MoHFW, ICDDR,B, JHU, Shimantik, DSH, SNL/Save The Children (USA), USAID, Thrasher Research Fund
Large reductions in colonization during the period of open, patent blood vessels Multiple cleansing sustains the reduction through first week of life